INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 49 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $239,000 | -2.4% | 300,000 | 0.0% | 0.00% | – |
| Q3 2020 | $245,000 | -74.7% | 300,000 | -77.0% | 0.00% | – |
| Q2 2020 | $967,000 | -8.7% | 1,304,000 | 0.0% | 0.00% | – |
| Q1 2020 | $1,059,000 | +15.6% | 1,304,000 | +44.2% | 0.00% | – |
| Q4 2019 | $916,000 | +17.9% | 904,000 | 0.0% | 0.00% | – |
| Q3 2019 | $777,000 | +44.2% | 904,000 | +49.7% | 0.00% | – |
| Q2 2019 | $539,000 | -9.4% | 604,000 | 0.0% | 0.00% | – |
| Q1 2019 | $595,000 | +9.2% | 604,000 | +0.7% | 0.00% | – |
| Q4 2018 | $545,000 | -45.9% | 600,000 | -40.0% | 0.00% | – |
| Q3 2018 | $1,008,000 | +21.4% | 1,000,000 | 0.0% | 0.00% | – |
| Q2 2018 | $830,000 | +3.0% | 1,000,000 | 0.0% | 0.00% | – |
| Q1 2018 | $806,000 | -0.5% | 1,000,000 | 0.0% | 0.00% | – |
| Q4 2017 | $810,000 | +3.1% | 1,000,000 | 0.0% | 0.00% | – |
| Q3 2017 | $786,000 | -27.3% | 1,000,000 | -9.1% | 0.00% | – |
| Q2 2017 | $1,081,000 | +5.1% | 1,100,000 | 0.0% | 0.00% | – |
| Q1 2017 | $1,029,000 | +3.7% | 1,100,000 | 0.0% | 0.00% | – |
| Q4 2016 | $992,000 | +153.1% | 1,100,000 | +214.3% | 0.00% | – |
| Q3 2016 | $392,000 | – | 350,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 15,003,000 | $13,500,000 | 6.56% |
| PenderFund Capital Management Ltd. | 9,605,000 | $10,735,000 | 2.51% |
| Silver Point Capital L.P. | 38,808,000 | $34,151,000 | 1.87% |
| Benefit Street Partners LLC | 5,045,000 | $4,440,000 | 1.69% |
| Context Capital Management, LLC | 11,279 | $10,168,000 | 0.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 57,791,000 | $51,920,000 | 0.92% |
| DeepCurrents Investment Group LLC | 30,292,000 | $27,169,000 | 0.81% |
| Saltoro Capital, LP | 1,800,000 | $1,623,000 | 0.66% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 20,481,000 | $18,638,000 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 64,548,000 | $58,191,000 | 0.24% |